Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS103HP-S in arthroscopic meniscectomy
NCT01406561Phase 3Completed
- Sponsor
- Omeros Corporation
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Large molecule
- Countries
- 1
01
Overview
A Phase 3 trial of OMS-103HP in meniscal tear, sponsored by Omeros Corporation. Started Aug 2011; status: completed.
02
Drugs
OMS-103HP
03
Conditions
meniscal tear
Beyond the preview
Go deeper on NCT01406561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01406561.